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Streptococcal  protein  G (SpG)  binds  immunoglobulin  G from  a broad  range  of  mammalian  species  with
high afﬁnity.  Chemical  conjugations  of  SpG  to  the  reporter  enzyme  horseradish  peroxidase  (HRP)  are
commonly  used  in immunohistochemical  applications.  However,  commercial  HRP  preparations  are  typ-
ically  isolated  from  horseradish  roots  as  varying  mixtures  of HRP  isoenzymes  with  different  biochemical
properties,  and chemical  conjugation  procedures  lead  to heterogeneous  HRP-SpG  preparations,  partially
including  inactivated  enzyme.  A  recombinant  process  allows  the  production  of a well-deﬁned  HRP isoen-
zyme  fused  to SpG  at  constant  1:1 stoichiometry  in a single  step  without  the need  for laborious  chemicalntibody
iagnostics
usion protein
eroxidase
rotein G
conjugation.  By  using  state-of-the-art  biotechnological  tools,  we  produced  a  recombinant  HRP-SpG  fusion
protein in  Pichia  pastoris  in bioreactor  cultivations.  Puriﬁed  HRP-SpG  was  tested  successfully  for func-
tional  binding  of  antibodies  from  different  mammalian  serums.  Recombinant  production  of  this  novel
well-deﬁned  fusion  protein  follows  quality-by-design  principles  and  facilitates  the  production  of  more
reliable  and  cost-effective  diagnostic  kits.
©  2015  The  Authors.  Published  by  Elsevier  B.V. This  is  an  open  access  article  under  the  CC  BY-NC-ND. Introduction
Staphylococcus and Streptococcus spp. produce surface proteins
hat bind tightly to the Fc region of immunoglobulin G (IgG)
Kronvall, 1973; Myhre and Kronvall, 1977). One of these recep-
ors is produced by Streptococcus spp. of the Lanceﬁeld group G,
ermed streptococcal protein G (SpG). SpG has been described to
ind a broad range of mammalian IgGs (Akerström et al., 1985;
jörck and Kronvall, 1984) via two (Fahnestock et al., 1986) or three
Abbreviations: ABTS, 2,2′-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)
iammonium salt; BSM, basal salts medium; BMGY, buffered minimal glycerol yeast
edium; BSA, bovine serum albumin; Ca-TBS, calcium-supplemented tris–buffered
aline; DCW, dry cell weight; ELISA, enzyme-linked immunosorbent assays; HRP,
orseradish peroxidase; IgG, immunoglobulin G; PTM1, trace element solution;
pG, streptococcal protein G; TMB, 3,3′ ,5,5′-tetramethylbenzidine dihydrochloride
ydrate; YE, BactoTM yeast extract; YNB, difcoTM yeast nitrogen base w/o amino
cids.
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/).license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
(Olsson et al., 1987) IgG binding domains. A schematic overview of
the domains of wildtype SpG is given in Fig. 1A.
The tight IgG binding capacity of SpG is commonly used
for detection and quantiﬁcation of antigens by coupling SpG
to a reporter enzyme, e.g., in Western blots or enzyme-linked
immunosorbent assays (ELISA). For instance, SpG conjugates were
recently used for the development of an indirect ELISA to detect
foot-and-mouth disease virus (Hosamani et al., 2015), in an
epidemiological study on the prevalence of antibodies against
the fungus Paracoccidioides brasiliensis in horses (Albano et al.,
2015), and in a study on detecting an infection with Mycobac-
terium avium suspecies paratuberculosis (Prieto et al., 2014). Owing
to the tight binding of SpG to IgGs from a large variety of
species, conjugates of a reporter enzyme with SpG were previ-
ously applied in studies on non-species dependent detection of
antibodies against melioidosis-inducing Burkholderia pseudomallei
(Mekaprateep et al., 2010), hantavirus (Lee et al., 2003), or Lyme
borreliosis-inducing Borrelia burgdorferi s. l. (Stöbel et al., 2002).
Most commonly, reporter enzymes such as alkaline phosphatase
or the heme-containing protein horseradish peroxidase (HRP) are
coupled to SpG by chemical conjugation, e.g., (Avrameas, 1969;
O’sullivan et al., 1978). Unfortunately, chemical conjugation pro-
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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Fig. 1. Schemes of SpG constructs. (A) Representation of wildtype SpG (based on UniProtID P19909) consisting of a signal peptide (sp), albumin and IgG binding domains (alb
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ithout hexahistidine tag (6x H) or pentaglycine linker (5x G); left, N-terminal fusio
ating factor alpha prepro signal peptide () facilitates secretion of the recombina
edures are not only time- and labor-intensive but also bear the
isk of inactivating the reporter enzyme and lead to heterogeneous
onjugate preparations.
Whereas SpG is currently produced recombinantly, e.g.,
Goward et al., 1990), HRP is still isolated from horseradish roots,
ntroducing yet another potential source for heterogeneity. Until
ecently, yields of recombinant HRP were limited in the low mg/L
ange (Krainer and Glieder, 2015) rendering a recombinant pro-
uction process uncompetitive. However, in the face of the latest
rogress made in our lab using the methylotrophic yeast Pichia pas-
oris as host organism (Krainer et al., in preparation), recombinant
RP production has become a feasible alternative. As opposed to
he isolation of HRP from its natural source, recombinant HRP pro-
uction is independent from environmental inﬂuences and allows
 steady enzyme supply at consistent quality. With regards to an
mmunohistochemical application, functional recombinant fusion
roteins of staphylococcal protein A-eGFP (Tang et al., 2008) and
nti-atrazine Fab-HRP (Koliasnikov et al., 2011) from P. pastoris
ave been described before. Recombinant fusion proteins allow
toichiometrically deﬁned preparations and are thus more homo-
eneous and reproducible than chemical conjugates. Making use of
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ig. 2. Production and puriﬁcation of recombinant HRP-SpG fusion protein. (A) Volum
ultivation in units per mL  cultivation supernatant and in units per mg total protein in th
B)  Size exclusion chromatogram of HRP-SpG after Ni2+ afﬁnity chromatography; black soe three IgG binding domains. (B) Recombinant SpG-HRP fusion constructs with or
pG to mature HRP; right, C-terminal fusions of SpG to mature HRP; the S. cerevisiae
ion constructs and is cleaved off by the cells in the process.
our recombinant HRP production platform in P. pastoris, we pro-
duced more than 110 mg/L of functional recombinant HRP-SpG
fusion protein in bioreactor cultivation.
2. Materials and methods
2.1. Strains and vectors
P. pastoris strains were based on the strain CBS 7435 (identi-
cal to NRRL Y-11430 and ATCC 76273) (Küberl et al., 2011) with
MutS phenotype (Krainer et al., 2012; Näätsaari et al., 2012). For
recombinant protein production we  used the previously described
strain PpFWK3 which facilitated the production of homogeneously
glycosylated recombinant proteins due to the inactivation of the
key mannosyltransferase Och1 (Krainer et al., 2013). Recombinant
SpG based on (Goward et al., 1990; Olsson et al., 1987) compris-
ing three IgG-binding sites (Fig. 1A) was codon-optimized (Abad
et al., 2010) and ordered as gBlock (Integrated DNA Technolo-
gies, Belgium). Using the primers listed in Supplementary Table
1, we  assembled seven fusion constructs of SpG and HRP C1A with
or without hexahistidine tag or pentaglycine linker (Fig. 1B). The
0 50 100
volume  mL
B
etric (black squares) and speciﬁc (gray triangles) HRP activities from bioreactor
e cultivation supernatant, respectively; one unit converts 1 mol of ABTS in 1 min.
lid line, A403; gray dotted line, A280.
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Fig. 3. Antigen detection with recombinant HRP-SpG fusion protein in direct ELISA. (A) IgGs from human and rabbit serums (dark gray diamonds and light gray squares,
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iespectively) were used as antigens at concentrations ranging from 20 to 0.02 g/m
rotein  G-HRP conjugate (dark gray triangles) or recombinant HRP-SpG fusion prot
t  a concentration of 0.1 g/mL. Error bars are standard deviations from triplicate m
scherichia coli–P. pastoris shuttle vector pPpT4 alpha S (Näätsaari
t al., 2012) was  ampliﬁed in E. coli, linearized by digestion with
miI to facilitate stable integration into the genome of P. pastoris,
nd used for transformation to PpFWK3 by electroporation (Lin-
ereghino et al., 2005) and heterologous expression by methanol
nduction.
.2. Production, puriﬁcation and characterization of HRP-SpG
Microscale cultivations were performed in 96-deep well plates
s described previously (Krainer et al., 2015; Weis et al., 2004).
ioreactor cultivation was performed in a BIOSTAT® B bioreac-
or (Sartorius, Germany). Concentrated cultivation supernatant of
exahistidine-tagged fusion proteins was loaded on a HisTrap FF
olumn (GE Healthcare, Austria), bound protein was eluted with
00 mM imidazole. Polishing of elution fractions was  performed by
ize exclusion chromatography (HiLoadTM 16/60 SuperdexTM 200
rep grade column; GE Healthcare). Eluted fusion protein species
ere analyzed by mass spectrometry to conﬁrm the identity of
he fusion protein, and by ELISA to demonstrate the presence of
oth fusion partners’ activities, IgG binding and HRP activity. Direct
LISA was done with human or rabbit IgG as antigens. HRP-SpG
usion protein was used at a concentration of 0.1 g/mL. Detailed
escriptions are given in Supplementary information.
. Results and discussion
Recombinant HRP-SpG fusion protein has a constant 1:1 stoi-
hiometry and is thus more homogeneous and reproducible than
hemical HRP-SpG conjugates, following quality-by-design prin-
iples. We  assembled seven HRP-SpG fusion protein constructs
Fig. 1B) and screened for HRP activity from microscale cultivations.
reviously, we found C-terminal fusions of tags to HRP to reduce
r even abolish HRP activity, whereas N-terminal fusions did not
esult in such a detrimental effect (Vogl et al., 2015). In the case of
 SpG-fusion however, three N-terminal fusions to HRP resulted in
lmost abolished HRP activity. The constructs 6xH-SpG-5xG-HRP
nd HRP-5xG-SpG (from N- to C-terminus) showed approximately
he same activity as wildtype HRP. Intriguingly, transformation of
onstructs with SpG fused to the C-terminus of mature HRP without
entaglycine linker (i.e., HRP-SpG and 6xH-HRP-SpG) even resulted
n P. pastoris strains producing three- to six-fold more HRP activity
han strains producing wildtype HRP. Ultimately, we chose the con-
truct 6xH-HRP-SpG for further experiments (nucleotide sequence
s shown in Supplementary information). At this point we  do not IgG from rabbit serum was used as antigen for detection with either a commercial
ght gray squares). HRP-SpG and a commercial protein G-HRP conjugate were used
rements.
have a rational explanation to interpret the distinct effect certain
fusion setups had on HRP activity yields and additional studies will
be necessary to draw non-speculative conclusions.
In order to produce sufﬁcient amounts for functional tests of
our HRP-SpG fusion protein, we cultivated the respective strain in
a 1.2 L-bioreactor. After 160 h of total cultivation time (136 h of
induction with methanol) we determined volumetric and speciﬁc
HRP activities. The volumetric activity was at 183 U/mL  with a spe-
ciﬁc activity of 227 U/mg (Fig. 2A). Since both activity parameters
were still increasing over time, even higher yields of target pro-
tein can be anticipated with prolonged cultivation time. Based on a
speciﬁc activity of 1624 ± 175 U/mg of puriﬁed HRP-SpG fusion pro-
tein (vide infra) we produced approximately 113 mg/L of HRP-SpG
fusion protein.
Following initial Ni2+ afﬁnity puriﬁcation, we  performed size
exclusion chromatography for polishing and followed the elution
pattern of protein and heme via the absorbances at 280 and 403 nm,
respectively. Interestingly, heme-containing protein eluted in a
smaller leading peak and a more dominant main peak (Fig. 2B),
presumably two different glycospecies of the same protein. The two
species can be either combined in order to maximize the yields of
functional HRP-SpG or the leading peak can be discarded in order
to maximize homogeneity.
To verify functional IgG binding of our HRP-SpG fusion pro-
tein we performed direct ELISA with immobilized IgG from either
human or rabbit serum as antigens. In both cases, a concentration-
dependent signal could be recorded (Fig. 3A), indicating binding
of our recombinant HRP-SpG fusion protein to IgGs of the two
tested species. The two  different glycospecies of our fusion pro-
tein that we separated via size exclusion chromatography both
showed the same HRP activity, as well as the same IgG binding
behavior, indicating that both species were indeed functional HRP-
SpG fusion proteins. In addition, we  veriﬁed the presence of both
fusion partners in the two  size exclusion peaks by mass spectrome-
try (Supplementary information), providing additional evidence for
our glycospecies hypothesis. When compared directly to a com-
mercial HRP-SpG chemical conjugate, our fusion protein showed
slightly lower sensitivity but a broader dynamic range (i.e.,  an
increase in absorbance over a broader range of IgG concentrations)
than the already optimized commercial product (Fig. 3B).4. Conclusions
In contrast to the current methodology, the production of a
recombinant HRP-SpG fusion protein is independent from the vary-
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Weis, R., Luiten, R., Skranc, W.,  Schwab, H., Wubbolts, M.,  Glieder, A., 2004. Reliable
high-throughput screening with Pichia pastoris by limiting yeast cell death
phenomena. FEMS Yeast Res. 5, 179–189, http://dx.doi.org/10.1016/j.femsyr.
2004.06.016.F.W. Krainer et al. / Journal o
ng quality and isoenzyme content of common horseradish root
solates as well as from the pitfalls of chemical conjugation proce-
ures. In this study, we identiﬁed a particular fusion construct of
RP and SpG to be well secreted by P. pastoris. When produced in
ioreactor cultivations, competitive yields of more than 110 mg/L
ere achieved. Previously reported yields of recombinant HRP from
. pastoris are typically in the 10 mg/L range, e.g., (Morawski et al.,
001, 2000). Direct ELISAs with IgGs from two mammalian species
onﬁrmed the applicability of the produced recombinant HRP-SpG
usion protein in immunohistochemistry.
Future studies will focus on using alternative HRP isoenzymes
Näätsaari et al., 2014) as fusion partner with higher catalytic activ-
ty towards common ELISA substrates to increase assay sensitivity.
lso, by performing directed evolution on the SpG fusion partner,
igher sensitivity, tighter IgG binding and an even broader IgG
inding range could be reached.
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